Accuray (ARAY) Misses Q1 EPS by 2c; Reaffims
Tweet
Share
E-mail
Get Alerts ARAY Hot Sheet
Price: $0.28 --0%
EPS Growth %: -400.0%
Financial Fact:
Research and development: 12.23M
Today's EPS Names:
OTLK, EGRX, MOVE, More
EPS Growth %: -400.0%
Financial Fact:
Research and development: 12.23M
Today's EPS Names:
OTLK, EGRX, MOVE, More
Join SI Premium – FREE
Accuray (NASDAQ: ARAY) reported Q1 EPS of ($0.11), $0.02 worse than the analyst estimate of ($0.09). Revenue for the quarter came in at $91 million versus the consensus estimate of $88.26 million.
GUIDANCE:
Accuray reaffirms FY2018 revenue of $390-400 million.
For earnings history and earnings-related data on Accuray (ARAY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
- Acurx Pharmaceuticals (ACXP) Tops Q2 EPS by 4c
- Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
